Cavity-Filling Mutations as a Strategy to Stabilize Prefusion Viral Fusion Proteins for Vaccine Design
Computational and Structural Biotechnology Journal · 01.03.2026 · 35 (1)
DOI: 10.34133/csbj.0199 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 19.08.2026. Verfasst von Reetesh Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Biotechnology, School of Biosciences & Technology, Galgotias University, Greater Noida, Uttar Pradesh 203201, India. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Enveloped viruses use metastable fusion proteins to enter host cells through large-scale conformational rearrangements. The prefusion conformation represents a higher-energy metastable state that irreversibly refolds into a lower-energy postfusion conformation during membrane fusion. Although the prefusion state contains the key neutralizing epitopes, it represents an ideal target for vaccine development. However, because of the instability of the prefusion state, the development of a viable vaccine and the determination of the prefusion state are both major challenges. Building on advances in structure-based vaccine design, cavity-filling mutations have emerged as a promising strategy for stabilizing prefusion viral fusion proteins across viral systems. Cavity-filling mutations have been shown in several viral systems to improve protein stability, thermostability, antigen expression, and immunogenicity. However, these effects depend on the structural architecture, cavity geometry, and local conformational context of each protein. In addition, these modifications may reduce premature transitions to the postfusion conformation and may help preserve critical neutralizing epitopes, depending on the structural context, while maintaining a metastable prefusion state. Accordingly, this review summarizes the molecular basis of cavity-filling-mediated stabilization, highlights successful applications across diverse viral families, examines how structural stabilization influences immunogenicity, and discusses the potential of cavity-filling strategies for rational vaccine design.
Autor:innen und Institutionen
- Department of Bioengineering and Biotechnology, School of Biosciences & Technology, Galgotias University, Greater Noida, Uttar Pradesh 203201, India.
- Department of Horticultural Science, Gyeongsang National University, Jinju, South Korea.
- Department of Life Sciences, School of Biosciences & Technology, Galgotias University, Gautam Buddha Nagar, Greater Noida 201310, India.
- Department of Biotechnology, GLA University, Mathura 281406, India.
- School of Forensic Sciences, Galgotias University, Greater Noida 201310, Uttar Pradesh, India.
- Department of Forensic Science, Sharda School of Allied Health Sciences, Sharda University, Greater Noida 201310, Uttar Pradesh, India.
ORCID-Profile: Reetesh Kumar, Himanshu Yadav, Naveen Kumar, Hyunsuk Shin
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kumar, R., Muthuramalingam, P., Tiwari, S., Gupta, J., Gupta, R., Agrawal, P., Yadav, H., Kumar, N., Rawat, J. M., Ravi, K., & Shin, H. (2026). Cavity-Filling Mutations as a Strategy to Stabilize Prefusion Viral Fusion Proteins for Vaccine Design. Computational and Structural Biotechnology Journal, 35(1). https://doi.org/10.34133/csbj.0199
Vancouver
Kumar R, Muthuramalingam P, Tiwari S, Gupta J, Gupta R, Agrawal P, et al. Cavity-Filling Mutations as a Strategy to Stabilize Prefusion Viral Fusion Proteins for Vaccine Design. Computational and Structural Biotechnology Journal. 2026;35(1). doi:10.34133/csbj.0199
BibTeX
@article{Kumar2026,
author = {Kumar, Reetesh and Muthuramalingam, Pandiyan and Tiwari, Savitri and Gupta, Jyoti and Gupta, Rohan and Agrawal, Prashant and Yadav, Himanshu and Kumar, Naveen and Rawat, Janhvi Mishra and Ravi, Karthikeyan and Shin, Hyunsuk},
title = {Cavity-Filling Mutations as a Strategy to Stabilize Prefusion Viral Fusion Proteins for Vaccine Design},
journal = {Computational and Structural Biotechnology Journal},
year = {2026},
volume = {35},
number = {1},
doi = {10.34133/csbj.0199}
}
EUVIMED